Research & development > Clinical diagnostics

New method for diagnosing malaria

28 November, 2012

Danish researchers have developed a new and sensitive method that makes it possible to diagnose malaria from a single drop of blood or saliva.


Best early-detection formula for breast cancer identified

27 November, 2012

La Trobe University researchers have identified the formula that works best in early detection of breast cancer.


Nanomedicine breakthrough improves chemotherapy for childhood cancer

20 November, 2012

In a world first, researchers from The University of New South Wales’ (UNSW) Australian Centre for NanoMedicine (ACN) have developed a nanoparticle that improves the effectiveness of chemotherapy for neuroblastoma by a factor of five.


Possible link between immune system and Alzheimer’s

16 November, 2012

An international research team, including scientists from the University of Toronto’s (U of T) Faculty of Medicine, has discovered a link between a mutation in an immune system gene and Alzheimer’s disease.


New drug target found for cystic fibrosis lung disease

09 November, 2012

Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway’s activity also decreases inflammation. The finding offers a potential new drug target for treating CF lung disease.


Measuring metabolism can predict the progress of Alzheimer’s

08 November, 2012

When it comes to Alzheimer’s disease, scientists usually look to the brain as their first centre of attention. Now researchers at Tel Aviv University (TAU) say that early clues regarding the progression of the disease can be found in the brain’s metabolism.


Breakthrough research into pancreatic cancer gene mutations

26 October, 2012

A large-scale international study into pancreatic cancer has discovered that the cancer is not just one disease, but many.


Naturally occurring compounds could fight ovarian cancer

19 October, 2012

A University of Canterbury (UC) research project, in collaboration with the University of Otago, Christchurch (formerly known as Christchurch School of Medicine), has shown some promising signs in the treatment of ovarian cancer.


Volunteers sought for edible vaccine trials

18 October, 2012

Researchers from The University of Western Australia, Ondek and Sir Charles Gairdner Hospital are continuing a study into how the bacteria responsible for stomach ulcers, Helicobacter pylori, can be used as a carrier for ingestible vaccines.


Thermo Fisher Scientific and Immundiagnostik collaborate on mass spectrometry-based clinical and research tools

17 October, 2012

Thermo Fisher Scientific and Immundiagnostik have announced a collaboration to develop novel mass spectrometry-based assays for qualitative and quantitative analysis of proteins and peptides. The goal is development of commercial assays to be widely applicable in research and routine clinical analysis.


Non-invasive test for colorectal cancer shows promise

17 October, 2012

A new non-invasive test for colorectal cancer screening has demonstrated high sensitivity for detecting colorectal cancer; in particular, precancers that are most likely to develop into cancer.


Scientists find new way to up safety factor of stem cell therapy

04 October, 2012

Researchers at the Mayo Clinic have found a way to detect and purge stem cells at risk of developing into tumours.


Nanotechnology device aims to prevent malaria deaths through rapid diagnosis

02 October, 2012

A pioneering mobile device using cutting-edge nanotechnology to rapidly detect malaria infection and drug resistance could revolutionise how the disease is diagnosed and treated.


I can hear big pharma screaming

24 September, 2012

A systematic review of the effects of antihypertensive drug therapy on people with mild hypertension has found no benefits come with the drugs. If this review is accurate, big pharma won’t be happy and the government will be thrilled.


Genetic test predicts risk for autism

18 September, 2012

A team of Australian researchers, led by the University of Melbourne, has developed a genetic test that is able to predict the risk of developing Autism Spectrum Disorder (ASD).


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd